Home > PS Ratio > VENUS REMEDIES

VENUS REMEDIES
PS (Price/Sales) Ratio

The Current P/S Ratio of VENUS REMEDIES is 0.61.

Share Price ₹296.2Feb 28,2025
Market Cap ₹396.9 Cr
Sales-TTM₹648.1 CrTTM-Consolidated Results
Price/Sales0.61xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of VENUS REMEDIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of VENUS REMEDIES is calculated as :

Current Market Cap [ ₹396.9 Cr] as on Feb 28,2025

(/) Sales [ ₹648.1 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 0.61x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for VENUS REMEDIES , the investors are currently willing to pay '0.61 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of VENUS REMEDIES !

The chart below summarizes the trend in P/S Ratio of VENUS REMEDIES over the last five years.

Historical PS (Price/Sales) ratio chart of VENUS REMEDIES


PS Ratio Performance Analysis for VENUS REMEDIES

- VENUS REMEDIES 's latest p/e ratio is 0.61x.

- VENUS REMEDIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.48x.

- VENUS REMEDIES 's operated at median p/e ratio of 0.6x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/e ratio peaked in Mar2024 at 0.73x.

- VENUS REMEDIES 's p/e ratio hit its five-year low in Mar2020 of 0.08x.


How does VENUS REMEDIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
VENUS REMEDIES 648.10.61396.9
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.57.41382,430.0
DIVIS LABORATORIES LTD9,078.016.02145,410.0
CIPLA LTD26,981.24.22113,950.0
TORRENT PHARMACEUTICALS LTD11,302.08.8299,682.3
DR REDDYS LABORATORIES LTD31,229.32.9993,261.6
MANKIND PHARMA LTD11,641.08.1294,482.5
ZYDUS LIFESCIENCES LTD22,247.43.9688,166.2
LUPIN LTD22,001.63.9687,025.8
AUROBINDO PHARMA LTD30,921.81.9961,445.9
ABBOTT INDIA LTD6,243.210.3764,747.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VENUS REMEDIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 0.61x
Max industry PS 16.02x
Median industry PS 4.22x
Average industry PS 6.22x



You may also like the below Video Courses